Allosteric Phosphatase Modulator - Silicon Therapeutics
Latest Information Update: 06 Feb 2021
At a glance
- Originator Silicon Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Phosphoric monoester hydrolase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 05 Feb 2021 Early research in Cancer in USA (unspecified route) Silicon (Therapeutics pipeline, January 2021)